Cryo-Cell International 

$6.19
16
+$0.04+0.65% Thursday 19:59

統計

當日最高
6.19
當日最低
5.83
52週最高
9.5
52週最低
3.67
成交量
3,701
平均成交量
4,734
市值
49.98M
市盈率
-
股息收益率
-
股息
-

即將到來

股息

0%股息收益率
10年增長
N/A
5年增長率
N/A
3年增長率
N/A
1年增長率
N/A

收益

15Oct預期
Q4 2022
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-1.35
-0.82
-0.3
0.23
預期每股收益
0.03
實際每股收益
0.13

人們還關注

此列表基於在 Stock Events 上關注 CCEL 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Services to the Health Industry
Health Services
Health Technology
Medical Specialties
Manufacturing
Dental Laboratories
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Show more...
首席執行官
員工
82
國家
US
ISIN
US2288951088

上市公司